I also thought there were assays outstanding but hiro stated...

I also thought there were assays outstanding but hiro stated otherwise.
Their assays have always taken considerable time to process with previous reasons including lab breakdowns.
I am unsure why reduction in shareholder notices have never been provided, though I believe this is not a company responsibility. You would imagine with the volume of shares traded, including the recent crossings, something should have been released to the market. A few questions to ask at the coming AGM I guess.
The SP looks like it did prior to the Dante purchase so the market has placed zero value on it. Something else to ask the board at the AGM?